Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
M3MTHRY +1.62%82 3-Year Book Growth Rate is 11.10% as of Mar. 2026, which is 50% below its 10-year median of 22.30. GuruFocus rates MTHRY with a GF Score™ of 82/100 and a GF Value™ of $8.07 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 580 Healthcare Providers & Services companies, M3 ranks better than 65.69% on this metric.
During the past 12 months, M3's average Book Value per Share Growth Rate was 9.70% per year.
During the past 3 years, the average Book Value per Share Growth Rate was 11.10% per year.
During the past 5 years, the average Book Value per Share Growth Rate was 15.20% per year.
During the past 10 years, the average Book Value per Share Growth Rate was 23.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of M3 was 38.60% per year. The lowest was 11.10% per year. And the median was 22.30% per year.
M3 (OTCPK:MTHRY) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
M3 3-Year Book Growth Rate Related Terms
MTHRY vs VEEV, BTSG, TEM: 3-Year Book Growth Rate Comparison
For the Health Information Services subindustry, M3's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
M3 3-Year Book Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, M3's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where M3's 3-Year Book Growth Rate falls into.
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 11.10% mean?
M3 (MTHRY) has a 3-Year Book Growth Rate of 11.10% as of Mar. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for M3 and its competitors. This is 50% below median its historical median of 22.30. Over the past decade, M3's 3-Year Book Growth Rate has ranged from 11.10 to 38.60. According to the industry distribution chart, M3 ranks #199 out of 580 companies in the Healthcare Providers & Services industry, placing it in the top 34.3%.
Is M3's 3-Year Book Growth Rate too high?
M3's current 3-Year Book Growth Rate of 11.10% is 50% below median its 10-year median of 22.30. Over the past 10 years, this metric has ranged from a low of 11.10 to a high of 38.60. The Healthcare Providers & Services industry median 3-Year Book Growth Rate is 5.40. M3's value of 11.10% is 105.6% above this industry median. Based on the distribution chart, M3 ranks #199 out of 580 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, M3 has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does M3's 3-Year Book Growth Rate compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, M3 ranks #199 out of 580 companies for 3-Year Book Growth Rate. This puts M3 in the upper half of its industry. The industry median 3-Year Book Growth Rate is 5.40. M3's value of 11.10% is 105.6% above this benchmark. Historically, M3's own 3-Year Book Growth Rate has ranged from 11.10 to 38.60 over the past decade. While the company's 10-year median is 22.30 vs. the industry median of 5.40, M3 has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Healthcare Providers & Services company?
The median 3-Year Book Growth Rate among Healthcare Providers & Services companies is 5.40, based on 580 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Book Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. M3's current 3-Year Book Growth Rate of 11.10% is 105.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for M3 and its competitors. For the Healthcare Providers & Services industry, the median 3-Year Book Growth Rate is 5.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. M3's current 3-Year Book Growth Rate is 11.10%, which is 50% below median its own 10-year median of 22.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M3 stock overvalued right now?
Based on GuruFocus' analysis, M3 (MTHRY) is currently considered Significantly Undervalued. The stock's GF Value™ is $8.07, compared to a current price of $5.65 — trading 30% below its estimated fair value. The current 3-Year Book Growth Rate is 11.10%, which is 50% below median its 10-year median of 22.30 and 105.6% above the Healthcare Providers & Services industry median of 5.40. M3's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For M3 (MTHRY), the current 3-Year Book Growth Rate is 11.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is M3 (MTHRY) Overvalued in 2026?
Based on GuruFocus' analysis, M3 stock appears to be undervalued.
The current stock price of $5.65 is trading 30% below its estimated GF Value™ of $8.07.
GuruFocus considers M3 to be Significantly Undervalued.
Key valuation signals for MTHRY:
3-Year Book Growth Rate: 11.10% (50% below median its 10-year median of 22.30)
GF Value™: $8.07 vs. price of $5.65 (30% below fair value)
Industry Position: 105.6% above the Healthcare Providers & Services median (#199 of 580)
No single metric tells the full story. See the MTHRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
M3 Inc is a Japan-based company engaged in providing medical-related services through internet-based platforms and real-world operations. The company operates six reportable segments: Medical Platform, Evidence Solutions, Career Solutions, Site Solutions, Patient Solutions, and Overseas. Its businesses include online marketing for medical professionals, clinical trial support, human resources services for medical professionals, operational support for medical institutions, and patient support services. The Overseas segment offers similar services internationally, including in the United States, the United Kingdom, China, South Korea, India, France, Germany, and Spain.
82GF Score
Get the complete analysis for MTHRY
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MTHRY has been successfully added to your 
